Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €0.61 EUR
Change Today +0.026 / 4.43%
Volume 0.0
As of 2:11 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

titan pharmaceuticals inc (TN7) Snapshot

Open
€0.61
Previous Close
€0.59
Day High
€0.61
Day Low
€0.61
52 Week High
06/8/15 - €0.90
52 Week Low
11/19/14 - €0.29
Market Cap
67.6M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
110.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TITAN PHARMACEUTICALS INC (TN7)

titan pharmaceuticals inc (TN7) Related Businessweek News

No Related Businessweek News Found

titan pharmaceuticals inc (TN7) Details

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company’s ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson’s disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.

13 Employees
Last Reported Date: 03/31/15
Founded in 1992

titan pharmaceuticals inc (TN7) Top Compensated Officers

President, Secretary and Director
Total Annual Compensation: $300.0K
Executive Chairman and Member of Executive Co...
Total Annual Compensation: $210.0K
Compensation as of Fiscal Year 2014.

titan pharmaceuticals inc (TN7) Key Developments

Titan Pharmaceuticals Inc. Amends Certificate of Incorporation

Titan Pharmaceuticals Inc. at its annual meeting of stockholders held on August 24, 2015, stockholders approved an amendment to the company's certificate of incorporation to effect a reverse split of the common stock within a range of one-for-three and one-for-eight, with the exact ratio to be determined by the board of directors at the appropriate time.

Titan Pharmaceuticals Inc., Annual General Meeting, Aug 24, 2015

Titan Pharmaceuticals Inc., Annual General Meeting, Aug 24, 2015., at 09:00 Pacific Standard Time. Location: 400 Oyster Point Boulevard. Agenda: To elect a board of eight directors to approve 2015 Omnibus Equity Incentive Plan; to approve an amendment to certificate of incorporation to effect a reverse split of common stock within a range from 1-for-3 to 1-for-8, with the exact ratio to be determined by board of directors; to ratify the appointment of OUM & Co. LLP as independent registered public accounting firm for the fiscal year ending December 31, 2015; to consider a non-binding advisory vote on executive compensation; to consider a non-binding advisory vote on the desired frequency of future non-binding advisory votes on executive compensation; and to consider and take action upon such other matters as may properly come before the meeting or any adjournment thereof.

Titan Pharmaceuticals Inc. Presents at BIO International Convention 2015, Jun-16-2015 04:15 PM

Titan Pharmaceuticals Inc. Presents at BIO International Convention 2015, Jun-16-2015 04:15 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Sunil Bhonsle, President, Secretary and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TN7:GR €0.61 EUR +0.026

TN7 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $61.17 USD +1.10
Reckitt Benckiser Group PLC 5,733 GBp +204.00
View Industry Companies
 

Industry Analysis

TN7

Industry Average

Valuation TN7 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 21.0x
Price/Book 36.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TITAN PHARMACEUTICALS INC, please visit www.titanpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.